Q-linea AB (publ) (QLINEA.ST)
SEK 0.04
(-1.61%)
SEK 0.04
(-1.61%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 46.52 Million SEK | 10.04% |
| 2022 | 42.28 Million SEK | 47.6% |
| 2021 | 28.64 Million SEK | 130.4% |
| 2020 | 12.43 Million SEK | 1243299900.0% |
| 2019 | 1.00 SEK | -100.0% |
| 2018 | 1.4 Million SEK | -2.37% |
| 2017 | 1.43 Million SEK | -59.26% |
| 2016 | 3.52 Million SEK | 0.0% |
| 2015 | - SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 40.39 Million SEK | -7.18% |
| 2024 Q1 | 43.51 Million SEK | -6.47% |
| 2023 Q1 | 48.19 Million SEK | 13.98% |
| 2023 FY | 46.52 Million SEK | 10.04% |
| 2023 Q4 | 46.52 Million SEK | 7.33% |
| 2023 Q3 | 43.35 Million SEK | -4.89% |
| 2023 Q2 | 45.57 Million SEK | -5.42% |
| 2022 Q2 | 18.7 Million SEK | -14.6% |
| 2022 Q4 | 42.28 Million SEK | 89.67% |
| 2022 Q1 | 21.89 Million SEK | -23.56% |
| 2022 FY | 42.28 Million SEK | 47.6% |
| 2022 Q3 | 22.29 Million SEK | 19.21% |
| 2021 Q4 | 28.64 Million SEK | 22.64% |
| 2021 Q2 | 22.59 Million SEK | 38.21% |
| 2021 Q1 | 16.34 Million SEK | 31.5% |
| 2021 FY | 28.64 Million SEK | 130.4% |
| 2021 Q3 | 23.35 Million SEK | 3.37% |
| 2020 Q4 | 12.43 Million SEK | 13468.82% |
| 2020 Q3 | -93 Thousand SEK | 59.03% |
| 2020 Q2 | -227 Thousand SEK | -5575.0% |
| 2020 Q1 | -4000.00 SEK | -400100.0% |
| 2020 FY | 12.43 Million SEK | 1243299900.0% |
| 2019 Q3 | 1.00 SEK | -100.0% |
| 2019 FY | 1.00 SEK | -100.0% |
| 2019 Q2 | 19.61 Million SEK | 122681.25% |
| 2019 Q4 | 1.00 SEK | 0.0% |
| 2019 Q1 | -16 Thousand SEK | 0.0% |
| 2018 Q1 | - SEK | -100.0% |
| 2018 FY | 1.4 Million SEK | -2.37% |
| 2018 Q4 | - SEK | -100.0% |
| 2018 Q3 | 1.00 SEK | -100.0% |
| 2018 Q2 | 165 Thousand SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2017 FY | 1.43 Million SEK | -59.26% |
| 2017 Q4 | 3.93 Million SEK | 0.0% |
| 2016 FY | 3.52 Million SEK | 0.0% |
| 2015 FY | - SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AddLife AB (publ) | 1.65 Billion SEK | 97.185% |
| Biotage AB (publ) | 437 Million SEK | 89.353% |
| Bonesupport Holding AB (publ) | 83.3 Million SEK | 44.148% |
| Doxa AB (publ) | - SEK | -Infinity% |
| Elekta AB (publ) | 3.25 Billion SEK | 98.572% |
| iZafe Group AB (publ) | 4.05 Million SEK | -1048.248% |
| Ortivus AB (publ) | 12.45 Million SEK | -273.441% |
| Ortivus AB (publ) | 12.45 Million SEK | -273.441% |
| S2Medical AB (publ) | 4.09 Million SEK | -1034.885% |
| Synsam AB (publ) | 707 Million SEK | 93.419% |